Journals / Turkish Journal of Hematology / 2010 / Cilt: 27 - Sayı: 3

Hematolojik hastalığı olan çocuklarda posterior geri dönüşümlü lökoensefalopati sendromu

Posterior reversible leukoencephalopathy syndrome in children with hematologic disorders

Pages
168–176
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We suggest that PRES can recover fully with early diagnosis and treatment whereas it can show poor prognosis depending on the etiology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Posterior reversible leukoencephalopathy syndrome (PRES) is characterized by headache, altered mental status, cortical blindness, and seizures associated with neuroradiological findings.
📊
Key Findings & Data:Materials and Methods: Here, we report PRES in six patients, aged 4 to 14 years, with diagnoses of leukemia and aplastic anemia.
💡
Conclusion & Impact:Conclusion: We suggest that PRES can recover fully with early diagnosis and treatment whereas it can show poor prognosis depending on the etiology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Posterior reversible leukoencephalopathy syndrome (PRES) is characterized by headache, altered mental status, cortical blindness, and seizures associated with neuroradiological findings. It involves predominantly white matter of the parieto-occipital lobes. Several medications and disorders play a role in the etiology of PRES. In this study, we aimed to show how the prognosis of PRES in hematological diseases of childhood might be according to the etiological factors. Materials and Methods: Here, we report PRES in six patients, aged 4 to 14 years, with diagnoses of leukemia and aplastic anemia. Results: Suggested causes in our patients were chemotherapeutics, hypertension, infection and antimicrobial drug administration, tumor lysis syndrome, acute renal failure and hemodialysis, immunosuppressive drug administration, and hypomagnesemia. One of the patients died of sepsis, renal failure and pulmonary hemorrhage and another died of relapse after total recovery from PRES. The other four patients are under follow-up without problems. Conclusion: We suggest that PRES can recover fully with early diagnosis and treatment whereas it can show poor prognosis depending on the etiology.

Özet

Amaç: Posterior geri dönüşümlü lökoensefalopati sendromu (PGDLS) nöroradyolojik bulgularla birlikte baş ağrısı, bilinç değişiklikleri, kortikal körlük ve nöbet ile seyreden bir sendromdur. Hastalık ağırlıklı olarak parieto-oksipital lobların beyaz cevherini tutar. Çeşitli ilaçlar ve hastalıklar PGDLS etiyolojisinde rol oynar. Bu çalışmada, çocukluk çağı hematolojik hastalıklarında altta yatan nedenlere göre PGDLS’nun nasıl seyrettiğini göstermeyi amaçladık. Yöntemve Gereçler: Burada, yaşları 4 ile 14 arasında olan, lösemi ve aplastik anemi tanıları ile izlenen PGDLS’lu 6 hastayı sunduk. Bulgular: Hastalarımızda kemoterapotikler, hipertansiyon, infeksiyon, antimikrobiyal ilaç kullanımı, tümör lizis sendromu, akut böbrek yetmezliği, hemodiyaliz, immünsüpresif ilaç kullanımı ve hipomagnezemiyi PGDLS nedenleri olarak tespit ettik. Hastalarımızdan birini sepsis, böbrek yetmezliği ve pulmoner hemaroji nedenleriyle, bir diğerini ise PGDLS tamamen düzeldikten sonra relaps nedeniyle kaybettik. Diğer dört hastamız herhangi bir problemi olmaksızın izlenmektedir. Sonuç: PGDLS erken tanı ve tedavi ile tamamen düzeltilebilir bir hastalık olmasına rağmen altta yatan nedene bağlı olarak kötü seyirli de olabilen bir sendromdur.

🔖

Cite This Article

MALBORA, B., AVCI, Z., DÖNMEZ, F., ALİOĞLU, B., BASKIN, E., ALEHAN, F., ÖZBEK, N. (2010). Hematolojik hastalığı olan çocuklarda posterior geri dönüşümlü lökoensefalopati sendromu. Turkish Journal of Hematology, Cilt: 27 - Sayı: 3, 168–176. https://ajindex.com/articles/412942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hinchey J, Chaves C, Appignanin B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy. N Engl J Med 1996; 334: 494-500
  2. Gupta A, Swaroop C, Rastogi R, Garg R, Bakhshi S. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol 2008;25:351-8
  3. Ozkan A, Hakyemez B, Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Taskapilioglu O, Altundal Y, Tunali A. Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology 2006;48:887-92
  4. Saito B, Nakamaki T, Nakashima H, Usui T, Hattori N, Kawakami K, Tomoyasu S. Reversible posterior leukoencephalopathy syndrome after repeat intermediatedose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol 2007;82:304-6
  5. Frye RE. Reversible posterior leukoencephalopathy syndrome in sickle-cell anemia. Pediatr Neurol. 2009;40:298-301
  6. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999;14:277-81
  7. Suminoe A, Matsuzaki A, Kira R, Fukunaga N, Nishio T, Hoshina T, Hara T. Reversible posterior leukoencephalopathy syndrome in children with cancers. J Pediatr Hematol Oncol 2003;25:236-9
  8. Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901-14
  9. Durrant S, Chipping PM, Palmer S, Gordon-Smith EC. Cyclosporin A, methylprednisolone, and convulsions. Lancet 1982;2:829-30
  10. Lee VH, Wijdicks EM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205-10
  11. Honkaniemi J, Kahara V, Dastidar P, Latvala M, Hietaharju A, Salonen T, Keskinen L, Ollikainen J, Vähämäki L, Kellokumpu-Lehtinen P, Frey H. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 2000;42:895-9
  12. Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007;33:230-6
  13. Sloane JP, Lwin KY, Gore ME, Powles RL, Smith JF. Disturbance of blood-brain barrier after bone marrow transplantatio